Ritonavir (brand name: Norvir) is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV in adults and children. Ritonavir is always used in combination with other HIV medicines. Although ritonavir is FDA-approved for the treatment of HIV infection, it is no longer used for its activity against HIV. Instead, ritonavir (given at low doses) is currently used as a pharmacokinetic enhancer to boost the activity of other HIV medicines. It is grouped under the following drug class(es): HIV-1 protease inhibitors. Its therapeutic use is listed as anti-infectives and antivirals. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Norvir, ABT-538, Empetus, Ritomune and Ritovir. Its PubChem CID is 392622.
Ritonavir
| CAS No | 155213-67-5 |
|---|---|
| Molecular Formula | C37H48N6O5S2 |
| Molecular Weight | 720.9 g/mol |
| Synonyms | 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
S. Food and Drug Administration (FDA) for the treatment of HIV in adults and children. Ritonavir is always used in combination with other HIV medicines. Although ritonavir is FDA-approved for the treatment of HIV infection, it is no longer used for its activity against HIV.
The listed CAS number is 155213-67-5.
The listed molecular formula is C37H48N6O5S2.
The listed molecular weight is 720.9 g/mol.
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate.
The source lists Norvir, ABT-538, Empetus, Ritomune and Ritovir.